CH621127A5 - - Google Patents
Download PDFInfo
- Publication number
- CH621127A5 CH621127A5 CH220676A CH220676A CH621127A5 CH 621127 A5 CH621127 A5 CH 621127A5 CH 220676 A CH220676 A CH 220676A CH 220676 A CH220676 A CH 220676A CH 621127 A5 CH621127 A5 CH 621127A5
- Authority
- CH
- Switzerland
- Prior art keywords
- radical
- phenyl
- compounds
- trialkylmethyl
- reacted
- Prior art date
Links
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 claims description 8
- -1 trialkylsilyl chloride Chemical compound 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- FJJYHTVHBVXEEQ-UHFFFAOYSA-N 2,2-dimethylpropanal Chemical compound CC(C)(C)C=O FJJYHTVHBVXEEQ-UHFFFAOYSA-N 0.000 claims description 6
- JKANAVGODYYCQF-UHFFFAOYSA-N prop-2-yn-1-amine Chemical compound NCC#C JKANAVGODYYCQF-UHFFFAOYSA-N 0.000 claims description 5
- 229910018540 Si C Inorganic materials 0.000 claims description 4
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 229910010271 silicon carbide Inorganic materials 0.000 claims description 4
- BVNYROHOUZCIEL-UHFFFAOYSA-N 2,2-diethylbutanal Chemical compound CCC(CC)(CC)C=O BVNYROHOUZCIEL-UHFFFAOYSA-N 0.000 claims description 3
- 150000000475 acetylene derivatives Chemical class 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 claims description 3
- 239000012965 benzophenone Substances 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000002262 Schiff base Substances 0.000 claims description 2
- 150000004753 Schiff bases Chemical class 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 description 13
- 239000000243 solution Substances 0.000 description 7
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 239000006193 liquid solution Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- IIVWHGMLFGNMOW-UHFFFAOYSA-N 2-methylpropane Chemical compound C[C](C)C IIVWHGMLFGNMOW-UHFFFAOYSA-N 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229940123685 Monoamine oxidase inhibitor Drugs 0.000 description 1
- OCBFFGCSTGGPSQ-UHFFFAOYSA-N [CH2]CC Chemical compound [CH2]CC OCBFFGCSTGGPSQ-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001408 amides Chemical group 0.000 description 1
- 239000002380 aminotransferase inhibitor Substances 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 1
- 239000012059 conventional drug carrier Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical compound C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical group [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- FRIJBUGBVQZNTB-UHFFFAOYSA-M magnesium;ethane;bromide Chemical compound [Mg+2].[Br-].[CH2-]C FRIJBUGBVQZNTB-UHFFFAOYSA-M 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 201000003102 mental depression Diseases 0.000 description 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 1
- 239000002899 monoamine oxidase inhibitor Substances 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/559,545 US3946060A (en) | 1975-03-18 | 1975-03-18 | Acetylene derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH621127A5 true CH621127A5 (da) | 1981-01-15 |
Family
ID=24234000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH220676A CH621127A5 (da) | 1975-03-18 | 1976-02-23 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US3946060A (da) |
| JP (1) | JPS51115425A (da) |
| BE (1) | BE839441A (da) |
| CA (1) | CA1073919A (da) |
| CH (1) | CH621127A5 (da) |
| DE (1) | DE2607527A1 (da) |
| DK (1) | DK31576A (da) |
| ES (1) | ES445661A1 (da) |
| FR (1) | FR2304349A1 (da) |
| GB (1) | GB1483324A (da) |
| IE (1) | IE42411B1 (da) |
| IL (1) | IL48913A (da) |
| MX (1) | MX3530E (da) |
| NL (1) | NL7601118A (da) |
| SE (1) | SE7601206L (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2533308A (en) * | 1946-06-07 | 1950-12-12 | Betten Philip | Meat holding device |
| US2655191A (en) * | 1950-07-27 | 1953-10-13 | Allen G Partin | Meat holding device |
| US4088667A (en) * | 1977-07-01 | 1978-05-09 | Merrell Toraude Et Compagnie | Lower alkyl 2-tri-(lower)alkylsilylacetylene-N-carbethoxyglycinates and process for using same |
| US4088668A (en) * | 1977-07-01 | 1978-05-09 | Merrell Toraude Et Compagnie | Acetylene derivatives |
| CH651838A5 (de) * | 1981-01-26 | 1985-10-15 | Sandoz Ag | 5-silyl-pent-2-en-4-inyl-1-amin-derivate, verfahren zu ihrer herstellung und ihre verwendung. |
| US4556723A (en) * | 1983-02-22 | 1985-12-03 | Minnesota Mining And Manufacturing Company | Process for the production of acyloins |
| US4661510A (en) * | 1983-08-17 | 1987-04-28 | Syntex (U.S.A.) Inc. | α-allenic-α-amino acids as enzyme inhibitors |
| JPS6055022A (ja) * | 1983-09-07 | 1985-03-29 | Sunstar Giken Kk | ポリウレタン樹脂組成物 |
| JP3483999B2 (ja) * | 1995-09-14 | 2004-01-06 | 東レ・ダウコーニング・シリコーン株式会社 | プリプレグおよびガラス繊維強化樹脂成形物 |
| AU2472499A (en) * | 1998-01-27 | 1999-08-09 | Thomas N. Thomas | Methods of treatment using mao-a and mao-b inhibitors such as l-deprenyl |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3210425A (en) * | 1960-09-07 | 1965-10-05 | Diamond Alkali Co | Amino polyacetylenic compounds |
| US3665026A (en) * | 1969-03-14 | 1972-05-23 | Gen Electric | Imidatosilanes |
| GB1314531A (en) * | 1969-07-30 | 1973-04-26 | Dow Corning Ltd | Organosilicon compounds |
| FR2105655A5 (da) * | 1970-09-16 | 1972-04-28 | Rhone Poulenc Sa | |
| US3856848A (en) * | 1973-12-26 | 1974-12-24 | Lilly Co Eli | Process for preparing a protected arginine |
-
1975
- 1975-03-18 US US05/559,545 patent/US3946060A/en not_active Expired - Lifetime
-
1976
- 1976-01-23 IE IE137/76A patent/IE42411B1/en unknown
- 1976-01-26 GB GB2854/76A patent/GB1483324A/en not_active Expired
- 1976-01-27 DK DK31576*#A patent/DK31576A/da not_active Application Discontinuation
- 1976-01-27 IL IL48913A patent/IL48913A/xx unknown
- 1976-02-04 SE SE7601206A patent/SE7601206L/ not_active Application Discontinuation
- 1976-02-04 NL NL7601118A patent/NL7601118A/xx not_active Application Discontinuation
- 1976-02-17 JP JP51015540A patent/JPS51115425A/ja active Pending
- 1976-02-17 CA CA245,928A patent/CA1073919A/en not_active Expired
- 1976-02-18 MX MX76328U patent/MX3530E/es unknown
- 1976-02-23 CH CH220676A patent/CH621127A5/de not_active IP Right Cessation
- 1976-02-25 DE DE19762607527 patent/DE2607527A1/de not_active Withdrawn
- 1976-02-28 ES ES445661A patent/ES445661A1/es not_active Expired
- 1976-03-11 BE BE165059A patent/BE839441A/xx unknown
- 1976-03-16 FR FR7607548A patent/FR2304349A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| NL7601118A (nl) | 1976-09-21 |
| IL48913A0 (en) | 1976-03-31 |
| JPS51115425A (en) | 1976-10-12 |
| FR2304349B1 (da) | 1980-07-18 |
| BE839441A (fr) | 1976-07-01 |
| GB1483324A (en) | 1977-08-17 |
| CA1073919A (en) | 1980-03-18 |
| ES445661A1 (es) | 1977-06-01 |
| DE2607527A1 (de) | 1976-09-30 |
| FR2304349A1 (fr) | 1976-10-15 |
| MX3530E (es) | 1981-02-02 |
| IE42411L (en) | 1976-09-18 |
| IE42411B1 (en) | 1980-07-30 |
| SE7601206L (sv) | 1976-09-19 |
| DK31576A (da) | 1976-09-19 |
| IL48913A (en) | 1980-12-31 |
| US3946060A (en) | 1976-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2434911C2 (de) | Phenyläthylamin-Derivate und pharmazeutische Zusammensetzungen | |
| DE2700091C2 (da) | ||
| CH621127A5 (da) | ||
| EP0003029B1 (de) | Neue 2-Oxo-1-pyrrolidinessigsäurederivate, Verfahren zu ihrer Herstellung, diese enthaltende Arzneimittel und deren Herstellung | |
| SE444931B (sv) | Beta, gamma-dihydropolyprenylalkoholer, farmaceutiska kompositioner innehallande desamma samt forfarande for deras framstellning | |
| DE2006978B2 (de) | N- [H3-Trifluormethyl-phenyl)-propyl-(2)] -glycinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| DE2711686B2 (de) | Verfahren zur Herstellung von Isobutyramiden | |
| EP0025109B1 (de) | 1-Benzoxepin-5(2H)-on-Derivate und ihre Salze sowie Verfahren zu deren Herstellung | |
| DE4131584A1 (de) | Imidazolylmethyl-pyridine, ihre herstellung und anwendung als pharmazeutika | |
| DE2462967C2 (de) | Derivate des 3-Amino-5-methyl-2-phenyl-pyrrols, deren Salze und diese enthaltende pharmazeutische Zubereitung | |
| EP0003298B1 (de) | 4-Hydroxy-2-benzimidazolin-thion-Derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel | |
| EP0110219B1 (de) | Heterocyclisch substituierte Nitrile, ihre Herstellung und Verwendung als Arzneimittel | |
| DE2725245A1 (de) | Methylaminderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische oder veterinaermedizinische zusammensetzungen | |
| DE2003744C2 (de) | In 3- und 4-Stellung disubstituierte 3-Amino-2-bicyclo[2,2,2]octan-2-ole, Verfahren zu deren Herstellung und dieselben enthaltende Arzneimittel | |
| DE2538593C3 (de) | m-Trifluormethylthio-phenäthylaminderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE1817861C3 (de) | N-alkylierte 3,4-Methylendioxymandelsäureamidine und deren pharmakologisch nicht giftige Säureanlagerungssalze und diese enthaltende pharmazeutische Mittel. Ausscheidung aus: 1811804 | |
| DE3323077A1 (de) | Racemische und optisch aktive eburnan-oxim-ether, verfahren zu deren herstellung und pharmazeutische praeparate, welche diese enthalten | |
| EP0185988B1 (de) | 10,11-Dihydro-5H-dibenzo[a,d]cycloheptadien-Derivate, ihre Herstellung und Verwendung | |
| DE2730312A1 (de) | (2-azabicyclo eckige klammer auf 2.2.2 eckige klammer zu octan-2-yl) diphenyl-alkanone, verfahren zu deren herstellung sowie dieselben enthaltende pharmazeutische praeparate | |
| DE2323555C3 (de) | N-substituierte Naphthalsäureimide | |
| DE2557517C3 (de) | Phenylessigsäurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE2354999C3 (de) | Dibenzo(b,f)azepin-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen | |
| DE2454805A1 (de) | Acylderivate | |
| CH640846A5 (en) | Aminoalkylfuran derivative | |
| CH535232A (de) | Verfahren zur Herstellung von neuen, substituierten Phenylessigsäuren und deren Estern |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |